Why Your Fund Is Not a Strategy Yet

Key Takeaways

• Fund size must align with market capital intensity and return timeline
• True strategy explains why the manager can capture mispriced health opportunities
• LPs evaluate coherence of thesis, team, risk framework, and ownership plan
• Access is valuable only when it improves sourcing and underwriting outcomes
• Exclusion criteria reveal disciplined logic and reduce capital traps

Pulse Analysis

In venture capital, especially within health and life sciences, the line between a fund’s description and its strategy is often blurred. LPs are no longer satisfied with a slide that lists a target fund size—whether €25 million (≈$27 million) or €100 million (≈$109 million)—and a broad sector focus. They want to see the operating logic that explains why the manager can consistently out‑perform peers in a crowded market. This means articulating a point‑of‑view that identifies mispriced opportunities, demonstrates unique access, and outlines a risk framework that matches the fund’s capital intensity and exit horizon.

A compelling strategy goes deeper than stating “we invest in healthtech” or “AI‑enabled healthcare.” It must pinpoint the specific market friction—such as distribution bottlenecks in European healthtech or under‑leveraged translational assets in biotech—and explain how the team’s expertise converts that friction into upside. Fund size becomes strategic only when tied to the stage and capital needs of the target assets; a €30 million (≈$33 million) seed diagnostics fund operates very differently from a €30 million series‑A care‑delivery fund. Moreover, disciplined exclusion criteria—clearly defining which scientific, regulatory, or commercial risks are off‑limits—signal to LPs that the manager can avoid capital traps that ensnare less rigorous investors.

Coherence is the final litmus test. LPs scrutinize whether the thesis, team background, ownership targets, reserve policy, and exit expectations form a self‑reinforcing system. When the strategy reshapes daily behavior—guiding which conferences to attend, which advisors to engage, and how investment memos are drafted—it moves from a fundraising pitch to an operating discipline. Managers who embed strategy into sourcing, underwriting, portfolio support, and LP reporting build the credibility needed to raise capital in a market that increasingly rewards disciplined, repeatable processes over enthusiastic narratives.